Stock Spotlight: Technology One Ltd (ASX:TNE)

About Technology One Ltd

Technology One Limited engages in the development, marketing, sale, implementation, and support of integrated enterprise business software solutions in Australia and internationally. It operates through Software and Consulting segments. The company offers various business software solutions, including business analytics, app builder, corporate performance management, curriculum, DxP local government, DxP Student, DxP Essentials, enterprise asset management, enterprise budgeting, enterprise cash receipting, enterprise content management, financials, human resources and payroll, performance planning, property and rating, spatial, student management, timetabling and scheduling, and supply chain management. It serves local government, education, government, health and community services, asset and project intensive, and financial services and corporate organizations. Technology One Limited was incorporated in 1983 and is headquartered in Fortitude Valley, Australia.


Source: EODHD



Key Stats

Source: EODHD. Data as of 19/06/26.

Price Performance

Growth Potential

  • Our valuation work across DCF, PE-multiple and EV/EBITDA suggests TNE is trading on fairly full multiples.
  • Management reaffirmed upgraded FY26 guidance of 16-18% ARR growth and 18-20% PBT growth.
  • Long-term growth – TNE aims to reach $1bn+ in ARR by FY30, driven by SaaS+ adoption, UK expansion, and AI innovation.
  • TNE has successfully transitioned 100% of its solutions to the single-fee SaaS+ model. This initiative has removed long, risky implementations and driven recurring revenue up to a massive 93% of total income.
  • The launch of the "Plus" AI agent is acting as a "Trojan horse" for upsells, with early customer usage exceeding internal models by over 10x (such as with James Cook University).
  • Potentially defensive characteristics given TNE’s core customers are non-cyclical public sector organizations.


Key Risks

  • Valuation risk given the company trades on high multiples.
  • Execution risk with expanding overseas.
  • Customer concentration risk – leveraged to the Australian and New Zealand public sector (potential risk from pressures on public budget spending).
  • Intensifying competitive pressures.
  • AI disruption risk – potentially reducing barriers for competitors to enter the market and put pressure on pricing.
  • Execution Risk on Unproven AI Commercial Models.
  • Cyber security / data breach risk.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.
September 9, 2026
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?
By Lavender Wong September 1, 2026
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.
August 31, 2026
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.
August 26, 2026
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.
August 26, 2026
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.
August 26, 2026
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.
August 19, 2026
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil
August 13, 2026
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.
August 6, 2026
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.